Summary
Patients with tracheal or major airway obstruction due to inoperable carcinomas are at a high risk of developing respiratory failure or post-obstructive pneumonia, or both. This often leads to death in days or weeks. In such cases there is usually an urgent need to restore the airway. This report details the short-term results and techniques used for the treatment of airway obstruction by direct intratumoural injection ofseveral anti-cancer drugs. A total of 93 patients with nearly complete extrinsic obstruction of at least one major airway were treated by injection of anti-cancer drugs directly into the endobronchial tumours or infiltrated bronchial mucosa through a flexible fiber-optic bronchoscope. At every session of treatment 1-3 ml each of50 mg/ml 5-fluorouracil, 1 mg/ ml mitomycin, 5 mg/ml methotrexate, 10 mg/ml bleomycin and 2 mg/ml mitoxantrone were injected separately at different sites without pre-mixing. Local Preliminary studies included a complete history and physical examination, posteroanterior and lateral chest X-rays, full blood cell count, prothrombin time, platelet count, spirometry and flow volume loops, and arterial blood gas analysis. The protocol of symptom scores, X-ray examinations, physiological tests and blood examinations were repeated every week during initial treatment, and before all subsequent bronchoscopies.
The extent of tumour seen at bronchoscopy was recorded on charts of the bronchial tree, and a microvideo camera (Olympus) was used for video documentation before and after all treatments for further comparative assessment. Computed tomography (CT) of the chest and abdomen with contrast infusion and rapid sequence imaging was employed to display the relationship between the involved bronchus and the surrounding structures, particularly the large intrathoracic blood vessels. Histologically, there were 71 squamous cell carcinomas, 14 small cell carcinomas, two adenocarcinomas, and one adenocystic carcinoma, as well as three other types of carcinoma.
After injecting 5 mg of diazepam intramuscularly, local anaesthesia with 2% xylocaine was used to numb the pharynx and larynx.
B
With the patient in sitting position, the flexible fiber-optic bronchoscope (Olympus IT10 and BF20d) was inserted transnasally into the trachea. Direct intratumoural injection was performed with a flexible needle (Olympus injector NM 8L, NM9L). Injection was made at the site of the endobronchial lesions. When the lesion was seen as a tumour in the bronchus, we selected as the site of the injection the tumour itself or the surrounding bronchial mucosa. When an infiltrating lesion was present, we injected anti-cancer drugs into the infiltrated mucosa ( figure, A) .
Injection of cytotoxic drugs intratumourally produced an immediate effect which led to necrosis of the tumour. One of the additional benefits of intratumoural injection of anticancer drugs is to provide a haemostatic effect on tumoural tissue, thus allowing piecemeal resection by forceps. Indeed, after intratumoural injections of anti-cancer drugs, a whiteyellow gel of necrotic tumour debris has been observed attached to the injected portion of the tumour or infiltrated mucosa. This material could easily be cleared with suction and by piecemeal resection using forceps, either at the same bronchoscopy session or during subsequent sessions (figure, B). The necrotic tumour debridement also allowed us to inject anticancer drugs more deeply into the tumour mass and infiltrated bronchial wall ( figure, C) .
Initially, intratumoural injections were given at one-to three-day intervals until airway patency could be restored. The average number of treatments required to achieve symptomatic response in a two-week period in 81 patients was four (range 1 -6). In patients with recurrent malignancies showing an initial response to this treatment, direct injection was carried out once a week for six to 10 weeks. If the patency of the airways was maintained, these intervals were increased to one or three months. Intratumoural chemotherapy was abandoned if the patency of the airways could not be established by a maximum of six successive sessions of injections and debridement with piecemeal resection, or when the severity of metastatic disease outweighed the potential benefits of continued In this report we present only short-term results obtained in a two-week period. The long-term results are under study and will be the subject of another publication.
